600422KPC Pharmaceuticals600422 info
$1.70info-2.66%24h
Global rank6719
Market cap$1.29B
Change 7d-14.89%
YTD Performance-42.19%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    KPC Pharmaceuticals (600422) Stock Overview

    KPC Pharmaceuticals, Inc, a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.

    600422 Stock Information

    Symbol
    600422
    Address
    No.166 Keyi RoadKunming, 650106China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.kpc.com.cn
    Country
    🇨🇳 China
    Phone Number
    86 871 6831 9868

    KPC Pharmaceuticals (600422) Price Chart

    -
    Value:-

    KPC Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.70
    N/A
    Market Cap
    $1.29B
    N/A
    Shares Outstanding
    757.99M
    N/A
    Employees
    5.32K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org